Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

U.S. Recommits To Improving Health, Education In Nigeria
The Guardian examines the recent U.S. commitment to continue support for the development of Nigeria"s health and education sector by Anne Fleuret, Nigeria"s acting mission director of USAID. At the conclusion of two USAID-funded projects in Nigeria, Fleuret said the HIV/AIDS programs were created six years ago "to empower communities." She added, "We envisioned so many things and we have substantially achieved that vision. We have provided support from the community level to the legislative level."

Cimzia(R), The Only PEGylated Anti-TNF, Recommended For Approval In The EU For Rheumatoid Arthritis
UCB announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending that the European Commission grants a marketing authorisation for Cimzia® (certolizumab pegol), in combination with methotrexate (MTX), for the treatment of moderate to severe active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs (DMARDs) including MTX, has been inadequate. In these patients, Cimzia® can be given as monotherapy in case of intolerance to MTX or when continued treatment with MTX is inappropriate. Cimzia® has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with MTX.
News of the day
U.S. Marshals Seize Drug Products Manufactured By Caraco Pharmaceutical Laboratories Ltd. FDA Acts To Prevent Repeated Drug Quality Problems
U.S. Marshals, at the request of the Food and Drug Administration, today seized drug products manufactured by Caraco Pharmaceutical Laboratories Ltd. (Caraco), at the company"s Michigan facilities in Detroit, Farmington Hills, and Wixom. The seizure also includes ingredients held at these same facilities. "The FDA is committed to taking enforcement action against firms that do not manufacture drugs in accordance with our good manufacturing practice requirements," said Janet Woodcock, M.D., director of the FDA"s Center for Drug Evaluation and Research. "Compliance with these standards prevents harm to the public."
Nutrition

Community Pharmacists Are No Longer On Shortage Occupation List

The Royal Pharmaceutical Society of Great Britain is concerned that from today, only pharmacists working in the NHS or hospitals will be on the shortage occupation list, which permits non-EU pharmacists and pre-registration trainees to get work visas. In September last year the UK Borders Agency Migration Advisory Committee recommended that community pharmacists and pharmacy technicians were on the list of shortage occupations, but in May it agreed to remove them. The Society believes that it, along with community pharmacy employers, should have been consulted about this decision. It is now unclear how the change to the list will affect the Society"s existing international members or international members in future. Wendy Harris, Deputy Registrar and Director of Regulation, said; "A decision was made rather quickly to take community pharmacists and pharmacy technicians off the shortage occupation list without any consultation with the Society. "We are now trying to ascertain exactly what this will mean. But there is a worry that this will affect overseas assessment programmes for qualified pharmacists from abroad who wish to work here, along with the 15 per cent of UK pharmacy students who are from overseas and choose to get their degree in Great Britain." The UK Borders Agency Migration Advisory Committee is reviewing medical occupations again in the autumn of 2009 and there is an opportunity to submit evidence in relation to pharmacists by July 15 for that review. This will be a chance to argue for the reinstatement of other pharmacists, including community pharmacists and pre-registration trainees, before the list is reviewed again in September. The Society is now considering what evidence to present and is working with other pharmacy bodies to ensure all relevant information is presented to the Migration Advisory Committee, in the hope it reverses its recent decision. Royal Pharmaceutical Society of Great Britain


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009